SCHEMBL7608745

SCHEMBL7608745

COCn1c(=O)c2[nH]cnc2n(C)c1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 11/20 0.71
▸ PDE4A P27815 9/20 0.71
▸ ADORA2A P29274 9/20 0.71
▸ PDE4B Q07343 9/20 0.71
▸ PDE4C Q08493 9/20 0.71
▸ PDE4D Q08499 9/20 0.71
▸ CFTR P13569 1/20 0.66
▸ ADORA3 P0DMS8 5/20 0.64
▸ ATAD2 Q6PL18 1/20 0.62
▸ PIK3CD O00329 1/20 0.60
▸ ALPL P05186 1/20 0.60
▸ TMIGD3 P0DMS9 1/20 0.60
▸ ADORA1 P30542 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ HIF1A Q16665 1/20 0.60
▸ LMNA P02545 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ CHIT1 Q13231 1/20 0.57
▸ CHIA Q9BZP6 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605748 0.88 ADORA2B (0.63) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL7457855 0.87 ADORA2B (0.76) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL7455363 0.86 ADORA2A (0.72) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL7016029 0.83 ADORA2A (1.00) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL7607714 0.82 CFTR (0.70) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL29581286 0.82 PDE4A (0.75) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL7460178 0.82 PDE4A (1.00) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL27598085 0.82 PDE4A (0.75) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL27522960 0.82 PDE4A (0.75) ADORA2BPDE4AADORA2APDE4BPDE4C
SCHEMBL17609664 0.81 PDE4A (0.61) ADORA2BPDE4AADORA2APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US claimed
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 — — EP disclosed
CN-1066146-C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof AVENTIS PHARMACEUTICALS AG (DE) 2001-05-23 — — CN disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 — — US disclosed
CN-1169993-A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof HOECHST AG (DE) 1998-01-14 — — CN disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 — — EP disclosed
Send feedback